Kindred Healthcare (KND) Tops Q2 EPS by 4c, Offers Guidance

Kindred Healthcare (NYSE: KND) reported Q2 EPS of $0.38, $0.04 better than the analyst estimate of $0.34. Revenue for the quarter came in at $1.84 billion versus the consensus estimate of $1.85 billion.

GUIDANCE:

Kindred Healthcare sees Q3 2016 EPS of $0.02-$0.12, versus the consensus of $0.14.

• EBITDAR to approximate $220 million to $235 million

Additionally, Kindred reaffirmed its preliminary outlook for 2017 core EBITDAR of at least $1 billion.

For earnings history and earnings-related data on Kindred Healthcare (KND) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c